GlassScriptPhysician profile
Aristides Miguel Estrada
NPI 1114970068
$4,823.54
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,857 · 2020: $842 · 2021: $791 · 2022: $921 · 2023: $392 · 2024: $20.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,106.71 | 2019-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $564.47 | 2019-2023 | Bevespi Aerosphere, Farxiga |
| Amgen INC. | $426.94 | 2019-2023 | Otezla, Repatha |
| Lilly USA, LLC | $342.49 | 2019-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $333.28 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $287.99 | 2019-2023 | |
| Amarin Pharma, INC. | $266.77 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $256.36 | 2019-2023 | Jardiance |
| Bausch Health US, LLC | $175.98 | 2019-2023 | Aplenzin, Wellbutrin |
| Pfizer INC. | $174.18 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.67 | 2021-2023 | |
| Comsort, INC | $150.00 | 2019 | |
| Allergan, INC. | $132.11 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $57.24 | 2019 | |
| Janssen Pharmaceuticals, INC | $54.84 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $48.00 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $42.35 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.33 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.49 | 2019 | |
| Astellas Pharma US INC | $27.94 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $27.24 | 2019-2021 | |
| Sanofi Pasteur INC. | $25.44 | 2019 | |
| Exact Sciences Corporation | $24.40 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $18.23 | 2021 | |
| Althera Pharmaceuticals LLC | $15.73 | 2021 | |
| Vivus LLC | $15.00 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.93 | 2020 | |
| Abbvie INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aristides Estrada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.